cas 4956-05-2|| where to buy 6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione

Nombre del producto:6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione

IUPAC Name:6-bromo-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione

Unidad de embalaje	Stock disponible	Precio($)
CM253184-25g	in stock	ŗȃ
CM253184-100g	in stock	ľƈŗ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 4956-05-2 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :4956-05-2; Fórmula molecular:C3H2BrN3O2; Punto de fusión:-; Código de sonrisas:O=C(N1)NN=C(Br)C1=O; Densidad:

: Número de catálogo:CM253184; Peso molecular:191.97; Punto de ebullición:; Nº Mdl:MFCD00154757; Almacenamiento:Keep in inert atmosphere, store at 2-8°C.

: Triazines; Triazines are an important class of six-membered aromatic heterocycles with three nitrogen atoms that give rise to three regioisomers: 1,2,4-triazines, 1,2,3-triazines, and 1,3, 5-triazine. 1,2,3-Triazines show remarkable reactivity and have attracted attention for their medicinal value. Triazine compounds fused with other carbon and heterocycles are stable and have a broad spectrum of pharmacological activities.

: ALG-055009; Aligos Therapeutics announced positive topline results from the Phase 2a HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction associated steatohepatitis (MASH) subjects. ALG-055009 demonstrated a favorable tolerability profile with no serious adverse events (SAEs), or clinical hyper/hypothyroidism. The majority of treatment emergent adverse events (TEAEs) were mild to moderate, with one discontinuation due to worsening insomnia in a subject with pre-existing insomnia.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.